Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Subst Abuse Treat. 2010 Jul 3;39(2):114–123. doi: 10.1016/j.jsat.2010.05.008

Table 1.

Trial characteristics

CTN
Trial #
Years
Conducted
Target
population
Diagnostic
Instrument
Trial
Sample
Opiate-
Primary
Subsample
OP Subsample
Characteristics
Age
Mean (SD)
Male
%
White race
%
Black race
%
Other race
%
0001 2001–02 Enrollees for inpatient opiate
detoxification services
DSM-IV Checklist 138 130 (94%) 36.3 (9.8) 60.8 56.2 16.9 26.9
0002 2001–02 Enrollees for outpatient opiate
detoxification services
DSM-IV Checklist 277 272 (98%) 38.7 (10.3) 71.6 37.3 35.8 26.9
0004 2001–04 Seekers of substance abuse
treatment services
SDSS 392 40 (10%) 36.7 (10.3) 60.0 72.5 12.5 15.0
0006 2001–03 Seekers of substance abuse
treatment services (drug-free clinics)
DSM-IV Checklist 469 13 (3%) 34.6 (8.8) 46.2 53.9 23.1 23.1
0007 2001–03 Seekers of substance abuse
treatment services (methadone clinics)
DSM-IV Checklist 454 214 (47%) 42.6 (8.5) 54.7 22.3 62.6 15.2
0009 2003–04 Seekers of smoking cessation services
at substance abuse treatment clinics
DSM-IV Checklist 366 177 (48%) 44.5 (9.6) 58.2 29.6 30.1 40.3
0013 2003–06 Pregnant seekers of substance abuse
treatment services
DSM-IV Interview 232 27 (12%) 26.1 (4.3) 0 29.6 7.4 63.0
0017 2004–06 IV drug users enrolled in drug
detoxification services
CIDI 679 108 (16%) 37.8 (9.4) 73.1 70.4 4.6 25.0
0018 2004–05 Male seekers of substance abuse
treatment services
CIDI 990 173 (17%) 42.9 (10.0) 100 52.3 26.2 21.5
0019 2004–05 Female seekers of substance abuse
treatment services
CIDI 814 242 (30%) 41.6 (8.9) 0 50.0 21.9 28.1
Aggregat
e
4,811 1,396 (29%) 40.5 (10.0) 55.6 43.5 30.0 27.5

Notes:

Trials selected by virtue of their enrollment of a treatment-seeking population and pre-treatment administration of both a DSM-IV diagnostic instrument and ASI-Lite. ‘Other race’ subsumes racial categories of Spanish/Latino, ‘Other,’ and multi-racial identification.

Additional information concerning individual trials is available at: http://ctndisseminationlibrary.org